Trimethoquinol selectively antagonizes contractions of rat gastric fundus to TXB2 and epoxymethano analogs of PGH2.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D011450:Prostaglandin Endoperoxides, Synthetic / Q000037:antagonists & inhibitors*; D011458:Prostaglandins E / Q000037:antagonists & inhibitors; D011463:Prostaglandins H; D051381:Rats; D013270:Stomach / Q000187:drug effects*; D013929:Thromboxane B2 / Q000037:antagonists & inhibitors*; D013931:Thromboxanes / Q000037:antagonists & inhibitors*; D014213:Tretoquinol / Q000494:pharmacology*
D007546:Isoquinolines; D011450:Prostaglandin Endoperoxides, Synthetic; D011458:Prostaglandins E; D011463:Prostaglandins H; D013931:Thromboxanes; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; D013929:Thromboxane B2; D014213:Tretoquinol; D000109:Acetylcholine